147
Participants
Start Date
November 30, 2015
Primary Completion Date
February 28, 2017
Study Completion Date
February 28, 2017
Bryostatin 1
The investigational drug product, bryostatin, is a sterile, pyrogen-free, lyophilized powder intended for IV infusion upon reconstitution and dilution. Placebo is a sterile, pyrogen-free, lyophilized powder intended for IV infusion upon reconstitution and dilution.
Placebo
The placebo is a sterile, pyrogen-free, lyophilized powder identical in appearance to the active drug, intended for IV infusion upon reconstitution and dilution.
Parker Jewish Institute for Health Care and Rehabilitation, New Hyde Park
Neurological Associates of Albany, PC, Albany
Alzheimer's Memory Center, Charlotte
iResearch Atlanta, Decatur
Atlanta Center for Medical Research, Atlanta
Compass Research, The Villages
Medical Research Group of Central Florida, Orange City
Compass Research, LLC, Orlando
Miami Jewish Health System, Miami
Brain Matters Research, Delray Beach
Alzheimer's Research and Treatment Center, Lake Worth
JEM Research, Atlantis
Axiom Clinical Research of Florida, Tampa
Neuropsychiatric Research Center of South Florida, Fort Myers
Neurology Clinic, PC, Cordova
Neurobehavioral Clinical Research, Canton
Alexian Brothers Neurosciences Institute Clinical Research, Elk Grove Village
Millennium Psychiatric Associates, Creve Coeur
University of Kansas Alzheimer's Disease Center, Fairway
Lake Charles Clinical Trials, Lake Charles
J. Gary Booker, MD APMC Clinical Drug Trials, Shreveport
Oklahoma Clinical Research Center, Oklahoma City
Xenoscience, Inc/ 21st Century Neurology, Phoenix
Nader Pharmacology Research Institute, Los Alamitos
ATP Clinical Research, Inc., Costa Mesa
San Francisco Clinical Research Center, San Francisco
Sunstone Clinical Research, Medford
Atlantic Neuroscience Institute, Springfield
The Clinical Trial Center, LLC, Jenkintown
Lead Sponsor
Neurotrope Bioscience, Inc.
INDUSTRY